These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 4750563)

  • 21. Nigro-striatal pathway: stimulation-evoked release of ( 3 H)dopamine from caudate nucleus.
    Voigtlander PF; Moore KE
    Brain Res; 1971 Dec; 35(2):580-3. PubMed ID: 5135554
    [No Abstract]   [Full Text] [Related]  

  • 22. Effects of morphine on striatal dopamine metabolism: possible mechanism of its opposite effect on locomotor activity in rats and mice.
    Kuschinsky K; Hornykiewicz O
    Eur J Pharmacol; 1974 Apr; 26(1):41-50. PubMed ID: 4598755
    [No Abstract]   [Full Text] [Related]  

  • 23. Characterization of dopaminergic influence on striatal-nigral neurotensin systems.
    Letter AA; Matsuda LA; Merchant KM; Gibb JW; Hanson GR
    Brain Res; 1987 Sep; 422(1):200-3. PubMed ID: 3119151
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo spontaneous and evoked release of newly synthesized dopamine in the cat caudate nucleus.
    Besson MJ; Cheramy A; Gauchy C; Glowinski J
    Adv Neurol; 1974; 5():69-78. PubMed ID: 4155237
    [No Abstract]   [Full Text] [Related]  

  • 25. In vivo voltammetric study of dopamine release in the striatum following microinjection of apomorphine into the substantia nigra zona reticulata.
    Kamata K; Sugimoto A; Kameyama T
    Jpn J Pharmacol; 1986 Mar; 40(3):472-7. PubMed ID: 3712872
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemical and electrical stimulation of the caudate nucleus in freely moving cats: the role of dopamine.
    Cools AR
    Brain Res; 1973 Aug; 58(2):437-51. PubMed ID: 4756136
    [No Abstract]   [Full Text] [Related]  

  • 27. D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems.
    Wachtel SR; Hu XT; Galloway MP; White FJ
    Synapse; 1989; 4(4):327-46. PubMed ID: 2532422
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Histochemical studies on the distribution of catecholamines and 5-hydroxytryptamine after intraventricular injections.
    Fuxe K; Ungerstedt U
    Histochemie; 1968; 13(1):16-28. PubMed ID: 5741831
    [No Abstract]   [Full Text] [Related]  

  • 29. The role of nigrostriatal dopamine in metabotropic glutamate agonist-induced rotation.
    Kearney JA; Becker JB; Frey KA; Albin RL
    Neuroscience; 1998 Dec; 87(4):881-91. PubMed ID: 9759976
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A topographic re-evaluation of the nigrostriatal projections to the caudate nucleus in the cat with multiple retrograde tracers.
    Hontanilla B; de las Heras S; Giménez-Amaya JM
    Neuroscience; 1996 May; 72(2):485-503. PubMed ID: 8737418
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modulation of neostriatal acetylcholine in the rat by dopamine and 5-hydroxytryptamine afferents.
    Butcher SH; Butcher LL; Cho AK
    Life Sci; 1976 Apr; 18(7):733-43. PubMed ID: 1263754
    [No Abstract]   [Full Text] [Related]  

  • 32. The effects of GBR 12909, a dopamine re-uptake inhibitor, on monoaminergic neurotransmission in rat striatum, limbic forebrain, cortical hemispheres and substantia nigra.
    Nissbrandt H; Engberg G; Pileblad E
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Jul; 344(1):16-28. PubMed ID: 1663587
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The role of dopamine in the physiology and pathology of the basal ganglia].
    Arushanian EB
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1972; 72(4):595-603. PubMed ID: 4341763
    [No Abstract]   [Full Text] [Related]  

  • 34. Topographic distribution and quantitative analysis of retrograde-labelled cells in the substantia nigra following administration of fluoro gold in the caudate putamen nucleus.
    Juanes JA; Bentivoglio M; Riesco JM; Chen S; Vázquez R
    Histol Histopathol; 1994 Jan; 9(1):65-72. PubMed ID: 8003823
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Non-dopaminergic nigrostriatal pathway.
    Guyenet PG; Crane JK
    Brain Res; 1981 Jun; 213(2):291-305. PubMed ID: 7248760
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Somatostatin-immunoreactive neurons in the rat striatum: effects of corticostriatal and nigrostriatal dopaminergic lesions.
    Salin P; Kerkerian-Le Goff L; Heidet V; Epelbaum J; Nieoullon A
    Brain Res; 1990 Jun; 521(1-2):23-32. PubMed ID: 1976412
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Histofluorescence of kainic acid-induced striatal lesions.
    Meibach RC; Brown L; Brooks FH
    Brain Res; 1978 Jun; 148(1):219-23. PubMed ID: 656926
    [No Abstract]   [Full Text] [Related]  

  • 38. Behavioral effects of direct- and indirect-acting dopaminergic agonists.
    Moore KE
    Adv Biochem Psychopharmacol; 1974; 12(0):403-14. PubMed ID: 4371765
    [No Abstract]   [Full Text] [Related]  

  • 39. Relation between rotation in the 6-OHDA lesioned rat and dopamine loss in striatal and substantia nigra subregions.
    Olds ME; Jacques DB; Kopyov O
    Synapse; 2006 Jun; 59(8):532-44. PubMed ID: 16565974
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Opposite effects of intranigral ibotenic acid and 6-hydroxydopamine on motor behavior and on striatal neuropeptide Y neurons.
    Nitsch C; Wolfrum G; Schaefer F; Scotti AL; Unger J
    Brain Res Bull; 1993; 30(1-2):21-32. PubMed ID: 8420631
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.